nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—Slurred speech—Procarbazine—brain cancer	0.0492	0.0492	CcSEcCtD
Neostigmine—Dysarthria—Lomustine—brain cancer	0.0366	0.0366	CcSEcCtD
Neostigmine—Abnormal behaviour—Temozolomide—brain cancer	0.0357	0.0357	CcSEcCtD
Neostigmine—Nystagmus—Procarbazine—brain cancer	0.0308	0.0308	CcSEcCtD
Neostigmine—Osteoarthritis—Lomustine—brain cancer	0.0251	0.0251	CcSEcCtD
Neostigmine—Dysarthria—Procarbazine—brain cancer	0.0233	0.0233	CcSEcCtD
Neostigmine—Coma—Procarbazine—brain cancer	0.0201	0.0201	CcSEcCtD
Neostigmine—Sweating increased—Procarbazine—brain cancer	0.0134	0.0134	CcSEcCtD
Neostigmine—Urinary incontinence—Carmustine—brain cancer	0.0133	0.0133	CcSEcCtD
Neostigmine—Urinary incontinence—Temozolomide—brain cancer	0.0128	0.0128	CcSEcCtD
Neostigmine—Pollakiuria—Procarbazine—brain cancer	0.0127	0.0127	CcSEcCtD
Neostigmine—Coma—Carmustine—brain cancer	0.0126	0.0126	CcSEcCtD
Neostigmine—Drowsiness—Procarbazine—brain cancer	0.0123	0.0123	CcSEcCtD
Neostigmine—Cardiovascular disorder—Etoposide—brain cancer	0.0121	0.0121	CcSEcCtD
Neostigmine—Chest discomfort—Etoposide—brain cancer	0.012	0.012	CcSEcCtD
Neostigmine—Flushing—Procarbazine—brain cancer	0.0103	0.0103	CcSEcCtD
Neostigmine—Arrhythmia—Procarbazine—brain cancer	0.00987	0.00987	CcSEcCtD
Neostigmine—Drowsiness—Hydroxyurea—brain cancer	0.00952	0.00952	CcSEcCtD
Neostigmine—Syncope—Procarbazine—brain cancer	0.00862	0.00862	CcSEcCtD
Neostigmine—Loss of consciousness—Procarbazine—brain cancer	0.00845	0.00845	CcSEcCtD
Neostigmine—Convulsion—Procarbazine—brain cancer	0.00833	0.00833	CcSEcCtD
Neostigmine—Arthralgia—Procarbazine—brain cancer	0.00819	0.00819	CcSEcCtD
Neostigmine—Sweating increased—Temozolomide—brain cancer	0.00813	0.00813	CcSEcCtD
Neostigmine—Dry mouth—Procarbazine—brain cancer	0.00801	0.00801	CcSEcCtD
Neostigmine—Vomiting—Lomustine—brain cancer	0.00786	0.00786	CcSEcCtD
Neostigmine—Shock—Procarbazine—brain cancer	0.00772	0.00772	CcSEcCtD
Neostigmine—Pollakiuria—Temozolomide—brain cancer	0.00771	0.00771	CcSEcCtD
Neostigmine—Tachycardia—Procarbazine—brain cancer	0.00766	0.00766	CcSEcCtD
Neostigmine—Hyperhidrosis—Procarbazine—brain cancer	0.00759	0.00759	CcSEcCtD
Neostigmine—Cardiac arrest—Etoposide—brain cancer	0.00734	0.00734	CcSEcCtD
Neostigmine—Nausea—Lomustine—brain cancer	0.00734	0.00734	CcSEcCtD
Neostigmine—Hypotension—Procarbazine—brain cancer	0.00733	0.00733	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00715	0.00715	CcSEcCtD
Neostigmine—Insomnia—Procarbazine—brain cancer	0.0071	0.0071	CcSEcCtD
Neostigmine—Somnolence—Procarbazine—brain cancer	0.00698	0.00698	CcSEcCtD
Neostigmine—Cramp muscle—Etoposide—brain cancer	0.00696	0.00696	CcSEcCtD
Neostigmine—Connective tissue disorder—Carmustine—brain cancer	0.00679	0.00679	CcSEcCtD
Neostigmine—Urinary tract disorder—Temozolomide—brain cancer	0.00659	0.00659	CcSEcCtD
Neostigmine—Bronchospasm—Etoposide—brain cancer	0.00657	0.00657	CcSEcCtD
Neostigmine—Connective tissue disorder—Temozolomide—brain cancer	0.00656	0.00656	CcSEcCtD
Neostigmine—Urethral disorder—Temozolomide—brain cancer	0.00655	0.00655	CcSEcCtD
Neostigmine—Sweating increased—Etoposide—brain cancer	0.0065	0.0065	CcSEcCtD
Neostigmine—Convulsion—Hydroxyurea—brain cancer	0.00645	0.00645	CcSEcCtD
Neostigmine—Gastrointestinal pain—Procarbazine—brain cancer	0.00642	0.00642	CcSEcCtD
Neostigmine—Flushing—Carmustine—brain cancer	0.00641	0.00641	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00629	0.00629	CcSEcCtD
Neostigmine—Urticaria—Procarbazine—brain cancer	0.00623	0.00623	CcSEcCtD
Neostigmine—Abdominal pain—Procarbazine—brain cancer	0.0062	0.0062	CcSEcCtD
Neostigmine—Flushing—Temozolomide—brain cancer	0.0062	0.0062	CcSEcCtD
Neostigmine—Arrhythmia—Carmustine—brain cancer	0.00617	0.00617	CcSEcCtD
Neostigmine—Mental disorder—Carmustine—brain cancer	0.00605	0.00605	CcSEcCtD
Neostigmine—Mediastinal disorder—Temozolomide—brain cancer	0.00602	0.00602	CcSEcCtD
Neostigmine—Nervous system disorder—Hydroxyurea—brain cancer	0.00596	0.00596	CcSEcCtD
Neostigmine—Skin disorder—Hydroxyurea—brain cancer	0.0059	0.0059	CcSEcCtD
Neostigmine—Mental disorder—Temozolomide—brain cancer	0.00585	0.00585	CcSEcCtD
Neostigmine—Hypersensitivity—Procarbazine—brain cancer	0.00578	0.00578	CcSEcCtD
Neostigmine—Asthenia—Procarbazine—brain cancer	0.00563	0.00563	CcSEcCtD
Neostigmine—Pruritus—Procarbazine—brain cancer	0.00555	0.00555	CcSEcCtD
Neostigmine—Agitation—Carmustine—brain cancer	0.00553	0.00553	CcSEcCtD
Neostigmine—Dyspnoea—Hydroxyurea—brain cancer	0.00541	0.00541	CcSEcCtD
Neostigmine—Somnolence—Hydroxyurea—brain cancer	0.0054	0.0054	CcSEcCtD
Neostigmine—Diarrhoea—Procarbazine—brain cancer	0.00537	0.00537	CcSEcCtD
Neostigmine—Agitation—Temozolomide—brain cancer	0.00534	0.00534	CcSEcCtD
Neostigmine—Urinary tract disorder—Etoposide—brain cancer	0.00528	0.00528	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00524	0.00524	CcSEcCtD
Neostigmine—Urethral disorder—Etoposide—brain cancer	0.00524	0.00524	CcSEcCtD
Neostigmine—Convulsion—Carmustine—brain cancer	0.00521	0.00521	CcSEcCtD
Neostigmine—Dizziness—Procarbazine—brain cancer	0.00519	0.00519	CcSEcCtD
Neostigmine—Convulsion—Temozolomide—brain cancer	0.00504	0.00504	CcSEcCtD
Neostigmine—Vomiting—Procarbazine—brain cancer	0.00499	0.00499	CcSEcCtD
Neostigmine—Flushing—Etoposide—brain cancer	0.00496	0.00496	CcSEcCtD
Neostigmine—Arthralgia—Temozolomide—brain cancer	0.00495	0.00495	CcSEcCtD
Neostigmine—Rash—Procarbazine—brain cancer	0.00495	0.00495	CcSEcCtD
Neostigmine—Dermatitis—Procarbazine—brain cancer	0.00494	0.00494	CcSEcCtD
Neostigmine—Headache—Procarbazine—brain cancer	0.00492	0.00492	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00491	0.00491	CcSEcCtD
Neostigmine—Dry mouth—Temozolomide—brain cancer	0.00484	0.00484	CcSEcCtD
Neostigmine—Mediastinal disorder—Etoposide—brain cancer	0.00482	0.00482	CcSEcCtD
Neostigmine—Tachycardia—Carmustine—brain cancer	0.00479	0.00479	CcSEcCtD
Neostigmine—Anaphylactic shock—Temozolomide—brain cancer	0.00474	0.00474	CcSEcCtD
Neostigmine—Nausea—Procarbazine—brain cancer	0.00466	0.00466	CcSEcCtD
Neostigmine—Nervous system disorder—Temozolomide—brain cancer	0.00465	0.00465	CcSEcCtD
Neostigmine—Skin disorder—Temozolomide—brain cancer	0.00461	0.00461	CcSEcCtD
Neostigmine—Hypotension—Carmustine—brain cancer	0.00459	0.00459	CcSEcCtD
Neostigmine—Hyperhidrosis—Temozolomide—brain cancer	0.00459	0.00459	CcSEcCtD
Neostigmine—Hypersensitivity—Hydroxyurea—brain cancer	0.00447	0.00447	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Carmustine—brain cancer	0.00447	0.00447	CcSEcCtD
Neostigmine—Muscle spasms—Etoposide—brain cancer	0.00447	0.00447	CcSEcCtD
Neostigmine—Insomnia—Carmustine—brain cancer	0.00444	0.00444	CcSEcCtD
Neostigmine—Dyspnoea—Carmustine—brain cancer	0.00438	0.00438	CcSEcCtD
Neostigmine—Somnolence—Carmustine—brain cancer	0.00436	0.00436	CcSEcCtD
Neostigmine—Asthenia—Hydroxyurea—brain cancer	0.00436	0.00436	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00432	0.00432	CcSEcCtD
Neostigmine—Insomnia—Temozolomide—brain cancer	0.00429	0.00429	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Carmustine—brain cancer	0.00424	0.00424	CcSEcCtD
Neostigmine—Dyspnoea—Temozolomide—brain cancer	0.00423	0.00423	CcSEcCtD
Neostigmine—Somnolence—Temozolomide—brain cancer	0.00422	0.00422	CcSEcCtD
Neostigmine—Diarrhoea—Hydroxyurea—brain cancer	0.00416	0.00416	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Temozolomide—brain cancer	0.0041	0.0041	CcSEcCtD
Neostigmine—Loss of consciousness—Etoposide—brain cancer	0.00409	0.00409	CcSEcCtD
Neostigmine—Convulsion—Etoposide—brain cancer	0.00403	0.00403	CcSEcCtD
Neostigmine—Dizziness—Hydroxyurea—brain cancer	0.00402	0.00402	CcSEcCtD
Neostigmine—Gastrointestinal pain—Carmustine—brain cancer	0.00401	0.00401	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00393	0.00393	CcSEcCtD
Neostigmine—Abdominal pain—Carmustine—brain cancer	0.00388	0.00388	CcSEcCtD
Neostigmine—Gastrointestinal pain—Temozolomide—brain cancer	0.00388	0.00388	CcSEcCtD
Neostigmine—Vomiting—Hydroxyurea—brain cancer	0.00386	0.00386	CcSEcCtD
Neostigmine—Rash—Hydroxyurea—brain cancer	0.00383	0.00383	CcSEcCtD
Neostigmine—Dermatitis—Hydroxyurea—brain cancer	0.00383	0.00383	CcSEcCtD
Neostigmine—Headache—Hydroxyurea—brain cancer	0.0038	0.0038	CcSEcCtD
Neostigmine—Anaphylactic shock—Etoposide—brain cancer	0.0038	0.0038	CcSEcCtD
Neostigmine—Urticaria—Temozolomide—brain cancer	0.00377	0.00377	CcSEcCtD
Neostigmine—Abdominal pain—Temozolomide—brain cancer	0.00375	0.00375	CcSEcCtD
Neostigmine—Tachycardia—Etoposide—brain cancer	0.00371	0.00371	CcSEcCtD
Neostigmine—Skin disorder—Etoposide—brain cancer	0.00369	0.00369	CcSEcCtD
Neostigmine—Hyperhidrosis—Etoposide—brain cancer	0.00367	0.00367	CcSEcCtD
Neostigmine—Hypersensitivity—Carmustine—brain cancer	0.00362	0.00362	CcSEcCtD
Neostigmine—Nausea—Hydroxyurea—brain cancer	0.00361	0.00361	CcSEcCtD
Neostigmine—Hypotension—Etoposide—brain cancer	0.00355	0.00355	CcSEcCtD
Neostigmine—Asthenia—Carmustine—brain cancer	0.00352	0.00352	CcSEcCtD
Neostigmine—Hypersensitivity—Temozolomide—brain cancer	0.0035	0.0035	CcSEcCtD
Neostigmine—Asthenia—Temozolomide—brain cancer	0.0034	0.0034	CcSEcCtD
Neostigmine—Dyspnoea—Etoposide—brain cancer	0.00338	0.00338	CcSEcCtD
Neostigmine—Somnolence—Etoposide—brain cancer	0.00337	0.00337	CcSEcCtD
Neostigmine—Diarrhoea—Carmustine—brain cancer	0.00336	0.00336	CcSEcCtD
Neostigmine—Pruritus—Temozolomide—brain cancer	0.00336	0.00336	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Etoposide—brain cancer	0.00328	0.00328	CcSEcCtD
Neostigmine—Dizziness—Carmustine—brain cancer	0.00325	0.00325	CcSEcCtD
Neostigmine—Diarrhoea—Temozolomide—brain cancer	0.00325	0.00325	CcSEcCtD
Neostigmine—Dizziness—Temozolomide—brain cancer	0.00314	0.00314	CcSEcCtD
Neostigmine—Vomiting—Carmustine—brain cancer	0.00312	0.00312	CcSEcCtD
Neostigmine—Gastrointestinal pain—Etoposide—brain cancer	0.0031	0.0031	CcSEcCtD
Neostigmine—Rash—Carmustine—brain cancer	0.0031	0.0031	CcSEcCtD
Neostigmine—Dermatitis—Carmustine—brain cancer	0.00309	0.00309	CcSEcCtD
Neostigmine—Headache—Carmustine—brain cancer	0.00308	0.00308	CcSEcCtD
Neostigmine—Vomiting—Temozolomide—brain cancer	0.00302	0.00302	CcSEcCtD
Neostigmine—Urticaria—Etoposide—brain cancer	0.00302	0.00302	CcSEcCtD
Neostigmine—Abdominal pain—Etoposide—brain cancer	0.003	0.003	CcSEcCtD
Neostigmine—Rash—Temozolomide—brain cancer	0.00299	0.00299	CcSEcCtD
Neostigmine—Dermatitis—Temozolomide—brain cancer	0.00299	0.00299	CcSEcCtD
Neostigmine—Headache—Temozolomide—brain cancer	0.00297	0.00297	CcSEcCtD
Neostigmine—Nausea—Carmustine—brain cancer	0.00292	0.00292	CcSEcCtD
Neostigmine—Nausea—Temozolomide—brain cancer	0.00282	0.00282	CcSEcCtD
Neostigmine—Hypersensitivity—Etoposide—brain cancer	0.0028	0.0028	CcSEcCtD
Neostigmine—Asthenia—Etoposide—brain cancer	0.00272	0.00272	CcSEcCtD
Neostigmine—Pruritus—Etoposide—brain cancer	0.00269	0.00269	CcSEcCtD
Neostigmine—Diarrhoea—Etoposide—brain cancer	0.0026	0.0026	CcSEcCtD
Neostigmine—Dizziness—Etoposide—brain cancer	0.00251	0.00251	CcSEcCtD
Neostigmine—Vomiting—Etoposide—brain cancer	0.00241	0.00241	CcSEcCtD
Neostigmine—Rash—Etoposide—brain cancer	0.00239	0.00239	CcSEcCtD
Neostigmine—Dermatitis—Etoposide—brain cancer	0.00239	0.00239	CcSEcCtD
Neostigmine—Headache—Etoposide—brain cancer	0.00238	0.00238	CcSEcCtD
Neostigmine—Nausea—Etoposide—brain cancer	0.00225	0.00225	CcSEcCtD
